1f33f93d-bee2-4646-8068-3e284f397365Q1 — 1st Quarter - ReportARNOLD & PORTER KAYE SCHOLER LLP
Law firm
Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.
MMM — Medicare/MedicaidIssues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.
Lobbyists: EUGENIA PIERSON; BOBBY MCMILLIN; mr PETER ERIC DUYSHART; VICTORIA DAVILA
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
HCR — Health IssuesIssues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.
Lobbyists: EUGENIA PIERSON; BOBBY MCMILLIN; mr PETER ERIC DUYSHART; VICTORIA DAVILA
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TRD — Trade (domestic/foreign)Issues related to trade and tariff policies pertaining to therapies for rare and ultra-rare diseases in the United States.
Lobbyists: EUGENIA PIERSON; BOBBY MCMILLIN; mr PETER ERIC DUYSHART; VICTORIA DAVILA
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.
Estimated value: $180/mo per user — but we made it free.